Compare BDTX & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | FCNCP |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | 18141 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | N/A |
| IPO Year | 2020 | N/A |
| Metric | BDTX | FCNCP |
|---|---|---|
| Price | $2.03 | $21.24 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.20 | N/A |
| AVG Volume (30 Days) | ★ 571.5K | 14.8K |
| Earning Date | 03-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.46 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $19.30 |
| 52 Week High | $4.94 | $22.86 |
| Indicator | BDTX | FCNCP |
|---|---|---|
| Relative Strength Index (RSI) | 39.11 | 46.68 |
| Support Level | $1.93 | $20.82 |
| Resistance Level | $2.30 | $21.33 |
| Average True Range (ATR) | 0.11 | 0.24 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 1.82 | 54.23 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
First Citizens BancShares Inc. is a Raleigh, N.C.-based financial holding company operating through its subsidiary, First-Citizens Bank & Trust Company. It provides comprehensive retail banking, commercial lending, leasing, and wealth management services via a nationwide branch network and digital platforms. In 2023 acquisition of Silicon Valley Bank, it also specializes in banking for tech, healthcare, and innovation firms.